Device Trial Radar · NCT06699797
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
Last checked: Nov 20, 2026Latest source record: Mar 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
56
Planned (sponsor's estimate)
Start
Feb 6, 2025
Primary completion
Apr 2027
Study completion Apr 2028
Sponsor
- Lead sponsor
- Envoy Medical CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 21, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if the Acclaim CI works to treat severe to profound sensorineural hearing loss in adults. It was also learn about the safety of the Acclaim CI implant. The main questions it aims to answer are: * Does the Acclaim CI device help participants hear words better compared to before the implants? * What medical problems do participants have after the Acclaim CI device was implanted? Participants will: * Have the Acclaim CI implanted; and * Visit the clinical site for checkups and tests at 1-Month, 3-Months, 6-Months, and at 1-year and 2-years after the device has been turned on.
Conditions
- Sensori-Neural Deafness
- Sensorineural Hearing Loss
- Sensorineural Hearing Loss (Disorder)
- Sensorineural Hearing Loss, Bilateral
- Sensorineural Hearing Loss, Profound
- Sensorineural Hearing Loss, Severe
Interventions
Acclaim Cochlear ImplantDevice
Participants with the Acclaim CI device will be tested during follow-up with their hearing results compared to baseline (before the device implant procedure).
Primary outcomes
What the sponsor says the trial is designed to measure.
- In the Safety Set, frequency and severity of device and procedure related adverse events, including device deficiencies, reported through 12-Month post-activationTime frame: From consent to the 1-year follow-up visit
1 more outcomes with a free account
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Center for Neurosciences Ear and Hearing Center
Tucson, Arizona
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.